AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimoso M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Ablus Pharma

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimoso M 2mg/500mg Tablet SR

Diabex Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are pivotal in diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, lightheadedness, headache, and tremors. Prompt glucose intake (e.g., sugary snacks or juice) is essential. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Uses of Glimoso M 2mg/500mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Glimoso M 2mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Glimoso M 2mg/500mg Extended-Release Tablet with food.

Common Side effects of Glimoso M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimoso M 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimoso M 2mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.

How Glimoso M 2mg/500mg Tablet SR works:

Glimoso M 2mg/500mg Extended-Release tablets contain glimepiride and metformin, two agents that manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimoso M 2mg/500mg SR tablets with alcohol is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimoso M 2mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Glimoso M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from the medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Exercise caution when administering Glimoso M 2mg/500mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Glimoso M 2mg/500mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimoso M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician before use. For those with mild to moderate liver disease, a low starting dose is typically advised; however, it's contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimoso M 2mg/500mg Tablet SR :

Should you forget to take a Glimoso M 2mg/500mg SR tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosage regimen. Avoid taking a double dose.

Facts to Know About Glimoso M 2mg/500mg Tablet SR

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Glimoso M 2mg/500mg Tablet SR

Maintain this medication within its original, sealed container. Store as directed on the packaging. Discard any remaining medicine. Prevent access by children, pets, and other individuals.
Lactic acidosis, a serious medical condition stemming from excessive blood lactic acid, is a potential consequence of Glimoso M 2mg/500mg Tablet SR use. This adverse reaction, also termed Metformin-associated lactic acidosis (MALA), is infrequent but poses a significant risk to individuals with compromised kidney function, the elderly, or those who consume substantial alcohol. Characteristic symptoms encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal pain, and bradycardia. The occurrence of these symptoms necessitates immediate cessation of Glimoso M 2mg/500mg Tablet SR and prompt medical attention.
Glimoso M 2mg/500mg extended-release tablets contain glimepiride and metformin, two medications used together to manage type 2 diabetes mellitus in adults. This combination therapy enhances blood sugar control when coupled with a healthy diet and regular physical activity. Glimepiride functions by stimulating the pancreas to release more insulin, thereby reducing blood glucose. Metformin reduces hepatic glucose production and increases insulin sensitivity. This formulation is unsuitable for treating type 1 diabetes.
Glimoso M 2mg/500mg SR tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headaches. Rare but potentially serious side effects such as lactic acidosis may also occur. Prolonged use might result in vitamin B12 deficiency.
Prolonged use of Glimoso M 2mg/500mg SR tablets can indeed lead to Vitamin B12 deficiency. This medication impairs the stomach's absorption of Vitamin B12. Untreated deficiency may result in anemia, neurological complications such as tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental Vitamin B12 is recommended annually by some experts.
Indeed, Glimoso M 2mg/500mg SR tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. This adverse effect is amplified by skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic agents. Consequently, consistent blood glucose monitoring is crucial. Readily available simple sugars, such as glucose tablets, honey, or fruit juice, should always be kept on hand.
Combining Glimoso M 2mg/500mg SR tablets with alcohol is unsafe due to the risk of significantly reduced blood glucose, potentially causing hypoglycemia. Furthermore, this combination elevates the likelihood of lactic acidosis.
Glimoso M 2mg/500mg Table...
73
MRP 89
17% off